2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
561
Leukemia
282
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Myelodysplastic Syndromes
111
Burkitt Lymphoma
91
Congenital Abnormalities
86
Lymphoma, Non-Hodgkin
85
Leukemia, Monocytic, Acute
84
Leukemia, Myelomonocytic, Acute
82
Lymphoma, Large B-Cell, Diffuse
80
Leukemia, Erythroblastic, Acute
75
Leukemia, Megakaryoblastic, Acute
72
Recurrence
70
Lymphoma, Mantle-Cell
70
Lymphoma, Follicular
49
Hodgkin Disease
44
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Lymphoma, Large-Cell, Immunoblastic
37
Blast Crisis
37
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
33
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Trastuzumab
628
Paclitaxel
577
Cyclophosphamide
555
Docetaxel
485
Capecitabine
402
Letrozole
376
Fulvestrant
327
Doxorubicin
294
Carboplatin
279
Tamoxifen
275
Anastrozole
243
exemestane
228
Radiotherapy
218
Epirubicin
211
Bevacizumab
196
palbociclib
189
pertuzumab
186
Vinorelbine
167
Lapatinib
167
Gemcitabine
166
pembrolizumab
162
Surveys and Questionnaires
139
Exercise
136
Magnetic Resonance Spectroscopy
123
Fluorouracil
119
Blood Specimen Collection
118
eribulin
117
Albumin-Bound Paclitaxel
117
Drug Therapy
111
130-nm albumin-bound paclitaxel
111
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Cytarabine
×
Clear all
NCT01645839
2019-06-12
DEPOSEIN
Centre Oscar Lambret
Phase 3
Completed
74 enrolled